SAN JOSE, Calif. – There was a time when relations between the FDA and device makers were almost entirely adversarial, but Jeff Shuren, director of the Center for Devices and Radiological Health, has unveiled yet another crowd-pleasing initiative in the form of a regulatory "super-office," designed to provide a streamlined, customized approach to device life cycle management. Read More
